Docetaxel Winthrop i kombination med doxorubicin og cyclophosfamid er indiceret til adjuverende behandling af patienter med operabel lymfeknude- positiv brystkræft.
Docetaxel Winthrop in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer.